ckd progression Search Results


90
MyBiosource Biotechnology ckd – progression
Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
Ckd – Progression, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckd+progression/ckd+++progression/pmc11103316-75-7-5
Average 90 stars, based on 1 article reviews
ckd – progression - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics, Biomarker Discovery, Concentration Assay

Study type, country and time frame for sample collection, definition of  CKD  and inclusion/exclusion criteria for the studies of fibroblast growth factor 23 in cats

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Study type, country and time frame for sample collection, definition of CKD and inclusion/exclusion criteria for the studies of fibroblast growth factor 23 in cats

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics, Medications, Concentration Assay, Biomarker Discovery, Imaging

Article characteristics and population information for studies evaluating serum or plasma concentrations of fibroblast growth factor-23 (pg/mL) in healthy cats and in cats with  CKD  stages 1–4

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of fibroblast growth factor-23 (pg/mL) in healthy cats and in cats with CKD stages 1–4

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics

Article characteristics and population information for studies evaluating serum or plasma concentrations of FGF-23 (pg/ml) in cats with progressive or non-progressive  CKD

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of FGF-23 (pg/ml) in cats with progressive or non-progressive CKD

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics